Third Rock Ventures as of June 30, 2015
Portfolio Holdings for Third Rock Ventures
Third Rock Ventures holds 4 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sage Therapeutics (SAGE) | 66.7 | $640M | 8.8M | 73.00 | |
| Blueprint Medicines (BPMC) | 20.4 | $196M | 7.4M | 26.49 | |
| Zafgen | 11.5 | $111M | 3.2M | 34.63 | |
| Eleven Biotherapeutics | 1.4 | $14M | 4.8M | 2.82 |
